Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4707-4712

  Chen, Cong Ying ^a   Shen, Jia Qing ^b   Wang, Feng ^a   Wan, Rong ^a   Wang, Xing Peng ^a,c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Annexin A1; Pancreatic ductal adenocarcinoma; Prognosis

Indexed keywords

EID: 84874015141     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4707     Document Type: Article

References (37)

1. Alldridge LC, Bryant CE (2003). Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res, 290, 93-107.
2. Alves VA, Nonogaki S, Cury PM, et al (2008). Annexin A1 subcellular expression in laryngeal squamous cell carcinoma. Histopathology, 53, 715-27.
3. Arur S, Uche UE, Rezaul K, et al (2003). Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev Cell, 4, 587-598.
4. Bai XF, Ni XG, Zhao P, et al (2004). Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol, 10, 1466-70.
5. Bhat K, Wang F, Ma Q, et al (2012). Advances in biomarker research for pancreatic cancer. Curr Pharm Des, 18, 2439-51.
6. Cui L, Wang Y, Shi Y, et al (2007). Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer. Proteomics, 7, 4192-202.
7. Da J, Meng X, Wang P, et al (2001). Significance on expressions of Annexin-I and its correlative gene proteins in endometrial hyperplasia, atypical hyperplasia and endometrial carcinoma. Zhonghua Bing Li Xue Za Zhi, 30, 256-9.
8. de Coupade C, Gillet R, Bennoun M, et al (2000). Annexin 1 expression and phosphorylation are upregulated during liver regeneration and transformation in antithrombin III SV40 T large antigen transgenic mice. Hepatology, 31, 371-80.
9. Fatimathas L, Moss SE (2010). Annexins as disease modifiers. Histol Histopathol, 25, 527-32.
10. Ferrone CR, Pieretti-Vanmarcke R, Bloom JP, et al (2012). Pancreatic ductal adenocarcinoma: Long-term survival does not equal cure. Surgery, 152, S43-9
11. Garcia Pedrero JM, Fernandez MP, Morgan RO, et al (2004). Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol, 164, 73-9.
12. Hannon R, Croxtall JD, Getting SJ, et al (2003). Aberrant inflammation and resistance to glucocorticoids in annexin 1-/- mouse. FASEB J, 17, 253-5.
13. Hayes MJ, Moss SE (2004). Annexins and disease. Biochem Biophys Res Commun, 322, 1166-70.
14. Horton P, Park KJ, Obayashi T, et al (2007). WoLF PSORT: protein localization predictor. Nucleic Acids Res, 35, W585-7.
15. Kang H, Ko J, Jang SW (2012). The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. Biochem Biophys Res Commun, 423, 188-94.
16. Kim KM, Kim DK, Park YM, et al (1994). Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett, 343, 251-5.
17. Kim YS, Ko J, Kim IS, et al (2003). PKCdelta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate. Eur J Biochem, 270, 4089-94.
18. Lim LH, Pervaiz S (2007). Annexin 1: the new face of an old molecule. FASEB J, 21, 968-75.
19. Lin CY, Jeng YM, Chou HY, et al (2008). Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J Surg Oncol, 97, 544-50.
20. Liu K, Qin CK, Wang ZY, et al (2012). Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels. Asian Pac J Cancer Prev, 13, 847-50.
21. Liu Y, Wang HX, Lu N, et al (2003). Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. World J Gastroenterol, 9, 645-9.
22. Moss SE, Morgan RO (2004). The annexins. Genome Biol, 5, 219.
23. Mulla A, Christian HC, Solito E, et al (2004). Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf), 60, 107-19.
24. Nomura H, Uzawa K, Yamano Y, et al (2009). Down-regulation of plasma membranous Annexin A1 protein expression in premalignant and malignant lesions of the oral cavity: correlation with epithelial differentiation. J Cancer Res Clin Oncol, 135, 943-9.
25. Perretti M, Croxtall JD, Wheller SK, et al (1996). Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med, 2, 1259-62.
26. Petrella A, Festa M, Ercolino SF, et al (2006). Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol Ther, 5, 643-7.
27. Radke S, Austermann J, Russo-Marie F, et al (2004). Specific association of annexin 1 with plasma membrane-resident and internalized EGF receptors mediated through the protein core domain. FEBS Lett, 578, 95-8.
28. Rescher U, Danielczyk A, Markoff A, et al (2002). Functional activation of the formyl peptide receptor by a new endogenous ligand in human lung A549 cells. J Immunol, 169, 1500-4.
29. Rhee HJ, Kim GY, Huh JW, et al (2000). Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem, 267, 3220-5.
30. Rodrigo JP, Garcia-Pedrero JM, Llorente JL, et al (2011). Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas. Hum Pathol, 42, 88-94.
31. Silistino-Souza R, Rodrigues-Lisoni FC, Cury PM, et al (2007). Annexin 1: differential expression in tumor and mast cells in human larynx cancer. Int J Cancer, 120, 2582-9.
32. Solito E, Kamal A, Russo-Marie F, et al (2003a). A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J, 17, 1544-6.
33. Solito E, Mulla A, Morris JF, et al (2003b). Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology, 144, 1164-74.
34. Taghavi A, Fazeli Z, Vahedi M, et al (2011). Pancreatic cancer mortality and misclassification--bayesian analysis. Asian Pac J Cancer Prev, 12, 2271-4.
35. Vishwanatha JK, Salazar E, Gopalakrishnan VK (2004). Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer, 4, 8.
36. Winter JM, Yeo CJ, Brody JR (2012). Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol, 52, S43-9.
37. Zhu F, Xu C, Jiang Z, et al (2010). Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Anat Rec, 293, 1310-4.